Skip to Content

P-5093

Main Content

Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation | 2019

Inferior outcomes with cyclosporine and mycophenolate mofetil after myeloablative allogeneic hematopoietic cell transplantation.

Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn J-Y, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Socié G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S

PubMed
PMID: 31158502

Abstract
Related Articles

CIBMTR Study #: GV14-01b

Working Committee: Graft-versus-Host Disease